Eli Lilly and Company
Denewsnov2 2 Promo 5fc5625c0e51c

DoD Looks to Lilly For COVID-19 Vaccine

Nov. 30, 2020
Along with the U.S. Department of Health and Human Services, the Department of Defense is hoping that Lilly's LY-CoV555 antibody therapeutic will stem the tide of COVID infections in the U.S. military ranks.

As part of Operation Warp Speed and a means of quickly finding effective treatment for the COVID-19 coronavirus, the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DoD) have agreed with Eli Lilly and Company to purchase the first doses of the company’s investigational antibody therapeutic bamlanivimab. The doses, also known as LY-CoV555, will be available for patient care if the U. S. Food and Drug Administration (FDA) authorizes their use.

HHS Secretary Alex Azar explained: “This agreement with Eli Lilly is part of Operation Warp Speed’s efforts to position the federal government to distribute potential therapeutics, allowing faster distribution if trials are successful.” He added: “More good news about COVID-19 therapeutics is constantly emerging, and the Trump Administration’s commitment to supporting potentially lifesaving therapeutics will help deliver these products to American patients without a day’s delay.”

The DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense and Army Contracting Command collaborated with the Biomedical Advanced Research and Development Authority, part of the HHS Office of the Assistant Secretary for Preparedness and Response, to provide $375 million to Lilly for 300,000 initial doses of bamlanivimab over the next two years. If the FDA authorizes use of the drug, the federal government will allocate the doses to state and territorial health departments which, in turn, will determine which healthcare facilities receive the intravenous (IV) infusion drug for outpatient care.

About the Author

Jack Browne | Technical Contributor

Jack Browne, Technical Contributor, has worked in technical publishing for over 30 years. He managed the content and production of three technical journals while at the American Institute of Physics, including Medical Physics and the Journal of Vacuum Science & Technology. He has been a Publisher and Editor for Penton Media, started the firm’s Wireless Symposium & Exhibition trade show in 1993, and currently serves as Technical Contributor for that company's Microwaves & RF magazine. Browne, who holds a BS in Mathematics from City College of New York and BA degrees in English and Philosophy from Fordham University, is a member of the IEEE.

Sponsored Recommendations

Wideband MMIC LNA with Bypass

June 6, 2024
Mini-Circuits’ TSY-83LN+ wideband, MMIC LNA incorporates a bypass mode feature to extend system dynamic range. This model operates from 0.4 to 8 GHz and achieves an industry leading...

Expanded Thin-Film Filter Selection

June 6, 2024
Mini-Circuits has expanded our line of thin-film filter topologies to address a wider variety of applications and requirements. Low pass and band pass architectures are available...

Mini-Circuits CEO Jin Bains Presents: The RF Engine of the 21st Century

June 6, 2024
In case you missed Jin Bains' inspiring keynote talk at the inaugural IEEE MTT-S World Microwave Congress last week, be sure to check out the session recording, now available ...

Selecting VCOs for Clock Timing Circuits A System Perspective

May 9, 2024
Clock Timing, Phase Noise and Bit Error Rate (BER) Timing is critical in digital systems, especially in electronic systems that feature high-speed data converters and high-resolution...